Kontafarma China Holdings (HKSE:01312) Days Payable : 9.12 (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Kontafarma China Holdings Days Payable?

Kontafarma China Holdings's average Accounts Payable for the six months ended in Dec. 2023 was HK$7.7 Mil. Kontafarma China Holdings's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$154.4 Mil. Hence, Kontafarma China Holdings's Days Payable for the six months ended in Dec. 2023 was 9.12.

The historical rank and industry rank for Kontafarma China Holdings's Days Payable or its related term are showing as below:

HKSE:01312' s Days Payable Range Over the Past 10 Years
Min: 13.27 Med: 72.33 Max: 254.58
Current: 13.27

During the past 13 years, Kontafarma China Holdings's highest Days Payable was 254.58. The lowest was 13.27. And the median was 72.33.

HKSE:01312's Days Payable is ranked worse than
98.46% of 974 companies
in the Drug Manufacturers industry
Industry Median: 87.765 vs HKSE:01312: 13.27

Kontafarma China Holdings's Days Payable declined from Dec. 2022 (21.46) to Dec. 2023 (9.12). It may suggest that Kontafarma China Holdings accelerated paying its suppliers.

Kontafarma China Holdings Days Payable Historical Data

The historical data trend for Kontafarma China Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kontafarma China Holdings Days Payable Chart

Kontafarma China Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

254.58

147.31

44.23

28.55

15.17

Kontafarma China Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															39.90	32.75	21.46	15.00	9.12

Competitive Comparison of Kontafarma China Holdings's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Kontafarma China Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kontafarma China Holdings's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kontafarma China Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where Kontafarma China Holdings's Days Payable falls into.

Kontafarma China Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Kontafarma China Holdings's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (21.398	+	6.674)	/	2 )	/	337.815	*	365
=	14.036					/	337.815	*	365
=	15.17

Kontafarma China Holdings's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (8.764	+	6.674)	/	2 )	/	154.388	*	365 / 2
=	7.719					/	154.388	*	365 / 2
=	9.12

Kontafarma China Holdings Days Payable Related Terms

Thank you for viewing the detailed overview of Kontafarma China Holdings's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Kontafarma China Holdings (HKSE:01312) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kontafarma China Holdings Ltd (HKSE:01312) » Definitions » Days Payable

Traded in Other Exchanges

N/A

Address

30 Harbour Road, Room 12A 09-20, 12th Floor, Sun Hung Kai Centre, Wanchai, Hong Kong, HKG

Website

https://www.kontafarma.com.hk

Kontafarma China Holdings Ltd is principally engaged in the manufacture and sale of prescription drugs including chemical drugs and traditional Chinese medicine in the PRC, and the operation of fitness centers, provision of fitness and health consulting services, and the operation of franchises. The operating segments include pharmaceutical business and Fitness business. Majority of its revenue derives from pharmaceutical business segment.

Kontafarma China Holdings (HKSE:01312) Headlines

No Headlines